Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers.
Joint inflammation initially induced by intraarticular injection of an aqueous suspension of peptidoglycan-polysaccharide (PG-PS) fragments isolated from Streptococcus pyogenes was reactivated by systemic injection of a normally subarthropathic dose of homologous or heterologous cell wall polymers, including muramyl dipeptide and lipopolysaccharide. Reactivation was not correlated with the severity of the initial inflammatory reaction. Results of studies utilizing 125I-labeled PG-PS fragments suggested that reactivation was associated with increased localization of PG-PS fragments in the joint following reinjection. These results indicate that the initial injury of the joint by S pyogenes PG-PS fragments increases the susceptibility of the joint to subsequent injury. Furthermore, once the inflammatory reaction is initiated, it can be perpetuated by a variety of ubiquitous cell wall polymers derived from normal flora as well as from pathogenic bacteria.
D000119:Acetylmuramyl-Alanyl-Isoglutamine; D000818:Animals; D001168:Arthritis / Q000209:etiology* / Q000473:pathology; D002458:Cell Fractionation; D002462:Cell Membrane / Q000032:analysis*; D004198:Disease Susceptibility; D005260:Female; D006614:Hindlimb; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008070:Lipopolysaccharides; D010457:Peptidoglycan; D011108:Polymers; D051381:Rats; D011919:Rats, Inbred Strains; D013297:Streptococcus pyogenes; D013997:Time Factors
D008070:Lipopolysaccharides; D010457:Peptidoglycan; D011108:Polymers; D000119:Acetylmuramyl-Alanyl-Isoglutamine